Bayesian Capital Management’s 89bio ETNB Stock Holding History

Bayesian Capital Management’s Portfolio ETNB Stock Details ETNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-23,000	Closed	-$436K	–	785
2023 Q2	$436K	Buy	+23,000	New	+$404K	0.05%	442
2023 Q1	–	Sell	-18,009	Closed	-$229K	–	884
2022 Q4	$229K	Buy	18,009 +3,400	+23%	+$30.6K	0.03%	559
2022 Q3	$85K	Buy	+14,609	New	+$64.2K	0.02%	607

Other funds holding ETNB

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Bayesian Capital Management's ETNB Position: Q3 2023 in Review

Bayesian Capital Management sold out of 89bio (ETNB) in Q3 2023, closing a stake of 23,000 shares — an estimated $436K sold.

Bayesian Capital Management first reported a position in ETNB in Q3 2022 and held it in 3 quarters. The position peaked at $436K in Q2 2023. 160 funds tracked by Wall St. Rank hold ETNB as of Q3 2023.

Bayesian Capital Management reported no remaining 89bio position as of Q3 2023 after selling out during the quarter.
Bayesian Capital Management sold 23,000 89bio shares in Q3 2023, an estimated $436K.
Bayesian Capital Management first reported a position in 89bio in Q3 2022 and held it in 3 quarters.
Bayesian Capital Management's 89bio position peaked at $436K in Q2 2023.
160 funds tracked by Wall St. Rank held 89bio as of Q3 2023.

Based on Bayesian Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.